Safety, tolerability, and pharmacokinetics of Aurora kinase B inhibitor AZD2811: a phase 1 dose-finding study in patients with advanced solid tumours.

Melissa Lynne JohnsonJudy S WangGerald FalchookCarol GreenleesSuzanne JonesDonald StricklandGiulia FabbriCaroline KennedyJ Elizabeth PeaseLiz SainsburyAlexander MacDonaldStein SchalkwijkPhilip SzekeresJan CosaertHoward A Burris

Published in: British journal of cancer (2023)

NCT02579226.

Keyphrases

open label
randomized controlled trial
tyrosine kinase
protein kinase
placebo controlled